Patent Board Allows McKool Client Challenge of Immunex
The U.S. Patent Trial and Appeal Board refused to deny a challenge by a French pharmaceutical to a patent held by Seattle-based Immunex. The ruling sets the stage for a full-scale challenge to a patent on drug treatment for allergies, rhinitis and other immune system problems. Natalie Posgate has the details in The Texas Lawbook.










